+

AU2001252192A1 - Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) - Google Patents

Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)

Info

Publication number
AU2001252192A1
AU2001252192A1 AU2001252192A AU5219201A AU2001252192A1 AU 2001252192 A1 AU2001252192 A1 AU 2001252192A1 AU 2001252192 A AU2001252192 A AU 2001252192A AU 5219201 A AU5219201 A AU 5219201A AU 2001252192 A1 AU2001252192 A1 AU 2001252192A1
Authority
AU
Australia
Prior art keywords
copd
agent
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252192A
Inventor
Marion Frankenberger
Konrad Maier
Gerhard Scheuch
Hans-Werner Ziegler-Heitbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of AU2001252192A1 publication Critical patent/AU2001252192A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catching Or Destruction (AREA)

Abstract

The invention describes a means for the treatment of diseases of the tracheo-bronchial tract, particularly of COPD.
AU2001252192A 2000-03-13 2001-03-13 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) Abandoned AU2001252192A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10012151 2000-03-13
DE10012151A DE10012151A1 (en) 2000-03-13 2000-03-13 Aerosol inhalant containing vitamin A compound in liposomes based on phosphatidylcholine, useful for treatment of tracheo-bronchial illnesses, especially chronic obstructive pulmonary disease
PCT/EP2001/002832 WO2001068081A1 (en) 2000-03-13 2001-03-13 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)

Publications (1)

Publication Number Publication Date
AU2001252192A1 true AU2001252192A1 (en) 2001-09-24

Family

ID=7634524

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252192A Abandoned AU2001252192A1 (en) 2000-03-13 2001-03-13 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)

Country Status (8)

Country Link
US (2) US7074389B2 (en)
EP (1) EP1263422B1 (en)
JP (1) JP2003528055A (en)
AT (1) ATE319439T1 (en)
AU (1) AU2001252192A1 (en)
DE (2) DE10012151A1 (en)
ES (1) ES2260213T3 (en)
WO (1) WO2001068081A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10012151A1 (en) 2000-03-13 2001-09-27 Gsf Forschungszentrum Umwelt Aerosol inhalant containing vitamin A compound in liposomes based on phosphatidylcholine, useful for treatment of tracheo-bronchial illnesses, especially chronic obstructive pulmonary disease
JP2005507934A (en) * 2001-10-30 2005-03-24 ネクター セラピューティックス エイエル，コーポレイション Water-soluble polymer conjugate of retinoic acid
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
WO2006025395A1 (en) * 2004-08-31 2006-03-09 Yasuhiko Shimizu Drug and treating system for chronic obstructive pulmonary disease by using carrier-free cell growth factor
US20160038593A1 (en) * 2004-12-22 2016-02-11 Nitto Denko Corporation Drug carrier and drug carrier kit for inhibiting fibrosis
JP2009221164A (en) * 2008-03-17 2009-10-01 Nitto Denko Corp Drug for treating pulmonary fibrosis
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
CN102343092A (en) * 2004-12-22 2012-02-08 日东电工株式会社 Drug carrier and drug carrier kit for inhibiting fibrosis
FR2889957B1 (en) * 2005-09-01 2008-06-27 Gerard Pieroni USE OF PHOSPHOLIPID DHA FOR THE PREPARATION OF A COMPOSITION FOR THE TREATMENT OF RESPIRATORY INSUFFICIENCY.
JP5342834B2 (en) * 2008-09-05 2013-11-13 日東電工株式会社 Treatment agent for myelofibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
US20080107723A1 (en) * 2006-09-28 2008-05-08 Perkins Walter R Methods of Treating Pulmonary Distress
TWI407971B (en) 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
US9707185B2 (en) * 2007-05-07 2017-07-18 Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Water-soluble nanoparticles containing water-insoluble compounds
US20080312174A1 (en) * 2007-06-05 2008-12-18 Nitto Denko Corporation Water soluble crosslinked polymers
EP2207570A2 (en) * 2007-09-14 2010-07-21 Nitto Denko Corporation Drug carriers
JP5210699B2 (en) * 2008-04-18 2013-06-12 ピアス株式会社 Retinoid stabilizing composition, skin external preparation and cosmetic containing the composition
US10196637B2 (en) 2011-06-08 2019-02-05 Nitto Denko Corporation Retinoid-lipid drug carrier
TWI658830B (en) 2011-06-08 2019-05-11 日東電工股份有限公司 HSP47 expression regulation and enhancement of retinoid liposomes
JP5727557B2 (en) * 2013-08-21 2015-06-03 日東電工株式会社 Treatment agent for pulmonary fibrosis
EP3645009A4 (en) * 2017-06-27 2021-03-31 The Ohio State Innovation Foundation Liponucleotide-based therapy for copd
JP2023528404A (en) * 2020-06-01 2023-07-04 アドベント セラピューティクス インコーポレイテッド Pharmaceutical compositions containing insoluble active ingredients

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
FR2591105B1 (en) * 1985-12-11 1989-03-24 Moet Hennessy Rech PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, OR COSMETIC, BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING A RETINOIDE OR A STRUCTURAL ANALOG OF SUCH A RETINOID AS A CAROTENOID.
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
DE3815221C2 (en) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Use of a retinol and / or retinoic acid ester-containing pharmaceutical preparation for inhalation for acting on the mucous membranes of the tracheo-bronchial tract, including the lung alveoli
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
JPH0334920A (en) * 1989-04-21 1991-02-14 Otsuka Pharmaceut Co Ltd Biologically active compound bonded to ribosome or combined with ribosome and medicine containing same compound
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
FR2658418B1 (en) * 1990-02-20 1994-09-02 Synthelabo PHARMACEUTICAL COMPOSITIONS BASED ON PHOSPHOLIPIDS.
WO1996004891A1 (en) * 1994-08-08 1996-02-22 Board Of Regents, The University Of Texas System Formulation and use of carotenoids in treatment of cancer
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation
US6183774B1 (en) * 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US6515022B2 (en) * 1996-04-19 2003-02-04 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the treatment of lung diseases
IN187969B (en) * 1996-12-10 2002-08-03 Johnson & Johnson Consumer
DE19652790A1 (en) * 1996-12-18 1998-06-25 Hermes Fabrik Pharm Praeparate Pharmaceutical preparations
DE10012151A1 (en) 2000-03-13 2001-09-27 Gsf Forschungszentrum Umwelt Aerosol inhalant containing vitamin A compound in liposomes based on phosphatidylcholine, useful for treatment of tracheo-bronchial illnesses, especially chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
ATE319439T1 (en) 2006-03-15
WO2001068081A1 (en) 2001-09-20
DE10012151A1 (en) 2001-09-27
US7074389B2 (en) 2006-07-11
US20030064094A1 (en) 2003-04-03
JP2003528055A (en) 2003-09-24
EP1263422A1 (en) 2002-12-11
US7476380B2 (en) 2009-01-13
DE50109156D1 (en) 2006-05-04
EP1263422B1 (en) 2006-03-08
ES2260213T3 (en) 2006-11-01
US20050220859A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
AU2001252192A1 (en) Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)
AP2003002842A0 (en) Phenethanolamine derivatives for treatment of respiratory disease.
WO2003000241A3 (en) Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases
GB0123951D0 (en) Therapies for treating respiratory diseases
MY126768A (en) Combinations of formoterol and fluticasone propionate for asthma
EP1363625A4 (en) Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
NO20041277L (en) Pharmaceutical preparations for the treatment of asthma.
YU35503A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
AU2002315150A1 (en) Enhanced auction mechanism for online transactions
EE200300212A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic diseases
WO2002047667A3 (en) Novel medicament compositions based on anticholinesterase drugs and on a steroid
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
AU6083899A (en) Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
ZA200104616B (en) Diazepinoindoles for the treatment of chronic obstructive pulmonary disease.
WO2002060533A3 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
BG106748A (en) Method and compositions for treating pulmonary diseases
AU2003205898A1 (en) Combination therapy for respiratory disorders
WO2001022956A3 (en) NOVEL COMBINATION OF LOTEPREDNOL AND β2-ADRENOCEPTOR AGONISTS
PL370459A1 (en) Substituted urea retinoid agonists ii
AU2002254930A1 (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists
UA83017C2 (en) Combination of roflumilast and r.r-formoterol for treatment of respiratory tract disorders
SI1458376T1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder
WO2001055214A3 (en) Asthma-associated gene
AU2002334116A1 (en) Therapies for treating respiratory diseases
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载